28 November 2023EuropeMarisa Woutersen

LSPN Spring: Life sciences cases taking centre stage at the UPC

UPC judge, EPO director and Regeneron counsel shed light on the court’s dynamics at London event | Life sciences sector emerging as a major player in the court | Quality of rulings and tight timeframes blamed for lack of appeals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Sanofi v Amgen antibody case lands front of queue at UPC

6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.

Big Pharma

UPC after one month: Life sciences cases

29 June 2023 Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP.

More on this story

Big Pharma

Sanofi v Amgen antibody case lands front of queue at UPC

6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.

Big Pharma

UPC after one month: Life sciences cases

More on this story

Big Pharma

Sanofi v Amgen antibody case lands front of queue at UPC

6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.

Big Pharma

UPC after one month: Life sciences cases